Prices are updated after-hours

Manufacturing 2021 - 07 - 13

KemPharm Inc

KMPH | $5.46 6.04% 0

(0.0% 1d) (0.7% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (NaN% volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 188,396,547
http://www.kempharm.com/
Sec Filling | Patents | 22 employees

(US) KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT™ technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.

urea treatment profitable

add to watch list Paper trade email alert is off

Capstone Green Energy Corp.

CGRN | $0.37 -18.49% 1.8M

Manufacturing

(0.0% 1d) (0.0% 1m) (-72.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (18.86% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 6,788,701
https://www.CapstoneGreenEnergy.com
Sec Filling | Patents | n/a employees

Capstone Green Energy is a leading provider of customized microgrid solutions and on-site energy technology systems focused on helping customers around the globe meet their environmental, energy savings, and resiliency goals. Capstone Green Energy focuses on four key business lines. Through its Energy as a Service (EaaS) business, it offers rental solutions utilizing its microturbine energy systems and battery storage systems, comprehensive Factory Protection Plan (FPP) service contracts that guarantee life-cycle costs, as well as aftermarket parts. Energy Conversion Products are driven by the Company's industry-leading, highly efficient, low-emission, resilient microturbine energy systems offering scalable solutions in addition to a broad range of customer-tailored solutions, including hybrid energy systems and larger frame industrial turbines. The Energy Storage Products business line designs and installs microgrid storage systems creating customized solutions using a combination of battery technologies and monitoring software. Through Hydrogen Energy Solutions, Capstone Green Energy offers customers a variety of hydrogen products, including the Company's microturbine energy systems.

energy msa battery batteries ycombinator

add to watch list Paper trade email alert is off

Quipt Home Medical Corp New

QIPT | $3.86 -2.28% -2.33% 88K

Manufacturing

(0.0% 1d) (-2.6% 1m) (-41.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-10.39% volume)
Earnings Calendar: 2023-12-18
Market Cap: $ 164,326,079
https://www.protechhomemedical.com
Sec Filling | Patents | n/a employees

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

respiratory education

add to watch list Paper trade email alert is off

Vicinity Motor Corp

VEV | $0.656 -4.44% -4.65% 34K

Manufacturing

(0.0% 1d) (-14.3% 1m) (-8.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (34.66% volume)
Earnings Calendar: 2023-11-15
Market Cap: $ 29,958,015
http://grandewest.com/
Sec Filling | Patents | 2021 employees

(CA) Vicinity Motor Corp. is a leading supplier of electric, CNG and clean-diesel vehicles for both public and commercial enterprise use in the U.S and Canada. The Company's flagship line of Vicinity™ buses, which maintains a market segment leadership position in Canada, is produced by the Company's world-class manufacturing partners and will be produced at the soon to be completed Buy America Act compliant assembly facility in the State of Washington. Vicinity's innovative Vicinity Lightning™ EV bus, enabled through a strategic supply agreement with BMW for batteries and components, seeks to lead the global transition to more sustainable transit vehicles in the private and public markets.

batteries eletrical vehicles

add to watch list Paper trade email alert is off

Greenbrook TMS Inc

GBNH | $0.121 -4.88% 6M

Manufacturing

(0.0% 1d) (0.0% 1m) (-79.0% 1y) (-24.5% 2d) (-24.5% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 4,936,822
https://greenbrooktms.com
Sec Filling | Patents | n/a employees

Operating through 123 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared,non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 370,000 TMS treatments to close to 10,000 patients struggling with depression.

treatment

add to watch list Paper trade email alert is off

ATAI Life Sciences N.V.

ATAI | $2.13 2.9% 950K

Manufacturing

(0.0% 1d) (24.0% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (-14.8% 7d) (7.5% volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 353,636,223
https://www.atai.life
Sec Filling | Patents | 35 employees

(DE) atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. atai's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies, seeking to effectively treat and ultimately heal mental health disorders. atai's mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. atai is headquartered in Berlin, with offices in New York and London.

treatment profitable msa

add to watch list Paper trade email alert is off

High Tide Inc.

HITI | $2.255 0.67% 460K

Manufacturing

(0.0% 1d) (37.8% 1m) (74.3% 1y) (0.0% 2d) (0.0% 3d) (-8.5% 7d) (NaN% volume)
Earnings Calendar: 2024-01-29
Market Cap: $ 178,901,478
https://hightideinc.com
Sec Filling | Patents | n/a employees

(CA) High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 80 branded retail cannabis locations spanning Ontario, Alberta, Manitoba and Saskatchewan. High Tide's retail segment features the Canna Cabana,KushBar, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its numerous consumption accessory businesses including e-commerce platforms Grasscity.com and CBDcity.com, and its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide's strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.

msa brands

add to watch list Paper trade email alert is off

Inspira Technologies Oxy B.H.N. Ltd

IINN | $1.94 0.52% 170K

Manufacturing

(0.0% 1d) (-0.5% 1m) (54.4% 1y) (0.0% 2d) (0.0% 3d) (-7.2% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 30,365,221
https://inspira-technologies.com
Sec Filling | Patents | 2021 employees

Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology, which it believes will elevate and stabilize patient oxygen saturation levels. The Company's ART technology potentially allows patients to remain awake during treatment while minimizing the use of the highly invasive, risky and costly mechanical ventilation systems that require medically induced coma. The Company's products have not yet been tested or used in humans and has not approved by the U.S. Food and Drug Administration (FDA).

treatment blood sensors respiratory

add to watch list Paper trade email alert is off

Palisade Bio Inc

PALI | $5.51 32.45% 28M

Manufacturing

(0.0% 1d) (1047.0% 1m) (115.5% 1y) (0.0% 2d) (0.0% 3d) (2.2% 7d) (NaN% volume)
Earnings Calendar: 2022-11-11
Market Cap: $ 70,368,293
https://www.palisadebio.com
Sec Filling | Patents | n/a employees

(US) Palisade Bio is a late-stage biopharma company advancing therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Positive data from Phase 2 trials of LB1148 demonstrated safety and tolerability as well as a statistically significant improvement in return to bowel function and decrease in length of stay in ICU and hospital compared to placebo. Palisade Bio believes that its investigational therapies have the potential to address the myriad health conditions and complications associated with chronic disruption of the gastrointestinal epithelial barrier.

education msa gastrointestinal

add to watch list Paper trade email alert is off

CareMax Inc - Class A

CMAX | $2.97 -8.62% 25K

Manufacturing

(0.0% 1d) (-23.3% 1m) (19.5% 1y) (0.0% 2d) (0.0% 3d) (1.9% 7d) (-72.3% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 11,294,563
https://www.caremax.com
Sec Filling | Patents | 962 employees

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

add to watch list Paper trade email alert is off

Better Choice Company Inc

BTTR | $6.33 24.12% 5.9M

Manufacturing

(0.0% 1d) (3436.8% 1m) (949.4% 1y) (0.0% 2d) (0.0% 3d) (-23.5% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 5,656,494
https://www.betterchoicecompany.com
Sec Filling | Patents | 44 employees

Better Choice Company Inc. is a growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. The company takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings and position its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.

animals brands pets

add to watch list Paper trade email alert is off

Cricut Inc - Class A

CRCT | $4.995 -0.1% -0.1% 820K

Manufacturing

(0.0% 1d) (-5.5% 1m) (-47.7% 1y) (0.0% 2d) (0.0% 3d) (-0.8% 7d) (31.08% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 252,689,637
https://cricut.com
Sec Filling | Patents | n/a employees

Cricut Inc. is a creative technology platform company dedicated to encouraging new ways for people to experience making at home. As an empowering lifestyle brand, Cricut’s mission is to unleash the creative potential of its users with innovations that bring ideas to life in the form of professional-looking, personalized handmade projects. Cricut’s industry-leading products include its flagship line of smart cutting machines—Cricut Maker®, the Cricut Explore® family, and Cricut Joy®— accompanied by other unique tools like Cricut EasyPress®, the Infusible Ink™ system, and a diverse collection of materials. In addition to Cricut’s core offerings, the brand also fosters a thriving community of more than four million dedicated users worldwide.

brands

add to watch list Paper trade email alert is off

Femasys Inc

FEMY | $1.315 -1.87% -1.9% 280K

Manufacturing

(0.0% 1d) (-30.9% 1m) (24.1% 1y) (0.0% 2d) (0.0% 3d) (-6.3% 7d) (104.81% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 29,060,641

Sec Filling | Patents | 35 employees

our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. the team is complemented by world-class medical advisors. our products have been organically conceived, researched and developed by the company and all manufacturing activities are conducted to ensure compliance with the u.s. food and drug administration (fda) per the requirements of 21 cfr 820, as well as iso 13485. femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the u.s. food and drug administration (fda), european union, canada, and japan with other select countries in process. making a difference in t

contraception

add to watch list Paper trade email alert is off